Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response

被引：0
|
作者：
Sophie Lehn
Nicholas P Tobin
Andrew H Sims
Olle Stål
Karin Jirström
Håkan Axelson
Göran Landberg
机构：
[1] Department of Laboratory Medicine,Center for Molecular Pathology
[2] Lund University,Cancer Center Karolinska
[3] Skåne University Hospital,Applied Bioinformatics of Cancer
[4] Karolinska Institutet and University Hospital,Division of Oncology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences
[5] University of Edinburgh Cancer Research Centre,Department of Clinical Sciences
[6] Linköping University,Translational Cancer Research
[7] Division of Pathology,Sahlgrenska Cancer Center
[8] Lund University,Breakthrough Breast Cancer Unit, School of Cancer and Imaging Sciences, Paterson Institute for Cancer Research
[9] Skåne University Hospital,undefined
[10] Department of Laboratory Medicine,undefined
[11] Lund University,undefined
[12] University of Gothenburg,undefined
[13] University of Manchester,undefined
来源：
BMC Cancer | / 14卷
关键词：
Yes-associated protein; Breast cancer; Estrogen receptor; Luminal A; 11q deletion; Tamoxifen response; Independent prognostic factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Clinical and prognostic significance of Yes-associated protein in colorectal cancer
    Wang, Yan
    Xie, Chengyao
    Li, Qingchang
    Xu, Ke
    Wang, Enhua
    TUMOR BIOLOGY, 2013, 34 (04) : 2169 - 2174
  • [32] Dual roles of yes-associated protein (YAP) in colorectal cancer
    Ou, Chunlin
    Sun, Zhenqiang
    Li, Shen
    Li, Guiyuan
    Li, Xiayu
    Ma, Jian
    ONCOTARGET, 2017, 8 (43) : 75727 - 75741
  • [33] Overexpression of yes-associated protein contributes to apoptosis of lung cancer
    Sun, Limei
    Zhang, Qingfu
    Ren, Hongjiu
    Xu, Yitong
    Jin, Ailin
    Qiu, Xueshan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (02): : 540 - 547
  • [34] Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies
    Bai, Haibo
    Gayyed, Mariana F.
    Lam-Himlin, Dora M.
    Klein, Alison P.
    Nayar, Suresh K.
    Xu, Yang
    Khan, Mehtab
    Argani, Pedram
    Pan, Duojia
    Anders, Robert A.
    HUMAN PATHOLOGY, 2012, 43 (09) : 1376 - 1385
  • [35] The Expression of Yes-Associated Protein (YAP) Maintains Putative Cancer Sternness and Is Associated with Poor Prognosis in Intrahepatic Cholangiocarcinoma
    Sugiura, Kensuke
    Mishima, Takashi
    Takano, Shigetsugu
    Yoshitomi, Hideyuki
    Furukawa, Katsunori
    Takayashiki, Tsukasa
    Kuboki, Satoshi
    Takada, Mamoru
    Miyazaki, Masaru
    Ohtsuka, Masayuki
    AMERICAN JOURNAL OF PATHOLOGY, 2019, 189 (09): : 1863 - 1877
  • [36] Yes-associated protein (YAP) molecule expression in odontogenic epithelium of ameloblastoma
    Anand, Rahul
    Sarode, Sachin C.
    Sarode, Gargi S.
    Rajpurohit, Ladu Singh
    Patil, Shankargouda
    CLINICAL ORAL INVESTIGATIONS, 2019, 23 (05) : 2389 - 2394
  • [37] Reduced Expression of RBP7 is Associated with Resistance to Tamoxifen In Luminal A Breast Cancer
    Yan, Xiaolu
    Gao, Zhe
    Zhang, Lixia
    Chen, Chuan
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (08) : 929 - 937
  • [38] Expression patterns of Yes-associated protein 1 in the developing mouse liver
    Wei, Wei
    Lotto, Jeremy
    Hoodless, Pamela A.
    GENE EXPRESSION PATTERNS, 2018, 29 : 10 - 17
  • [39] Aberrant methylation of yes-associated protein (YAP1) as a potential biomarker in breast cancer
    Ramadan, Ragaa Abdelkader
    Elkarmouty, Ahmed
    Elnaggar, Mostafa
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2019, 20 (01)
  • [40] Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer
    E. A. Reijm
    M. P. H. M. Jansen
    K. Ruigrok-Ritstier
    I. L. van Staveren
    M. P. Look
    M. E. Meijer van Gelder
    A. M. Sieuwerts
    S. Sleijfer
    J. A. Foekens
    E. M. J. J. Berns
    Breast Cancer Research and Treatment, 2011, 125 : 387 - 394
12345